
TMO Stock Analysis
Thermo Fisher Scientific Inc
HEALTHCARE
DIAGNOSTICS & RESEARCH
Annualized: $1.88 • Yield: 0.28%
Last ex-dividend: 2026-09-15. Dividend payments can change or be suspended.Performance Overview
Trailing adjusted-close returns as of 2026-07-31. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 25, 2026
TMO Stock Analysis: Why Thermo Fisher Scientific Inc Scored 17% in Stock Value Finder
Thermo Fisher Scientific Inc (TMO) StockValueFinder Review
Thermo Fisher Scientific Inc is a leading provider of scientific instruments, consumables, software, services, and solutions for the life sciences, analytical chemistry, diagnostics, pharmaceuticals, academic research, environmental, and industrial markets. This article provides an educational review of Thermo Fisher Scientific Inc (TMO) using StockValueFinder's metrics to help investors understand the financial health and valuation of this company.
Why the StockValueFinder Score Matters
StockValueFinder evaluates companies based on a variety of financial metrics that indicate profitability, efficiency, debt management, and valuation. The overall score for Thermo Fisher Scientific Inc is 17%, which falls below the threshold typically considered attractive by StockValueFinder's criteria. This low score is reflected in its rating: AVOID.
EPS Strength and Consistency
Earnings Per Share (EPS) measures a company’s profitability on a per-share basis, indicating how much profit each outstanding share of stock has generated over time. The EPS test for Thermo Fisher Scientific Inc did not pass according to StockValueFinder's criteria, which suggests the company may have inconsistent or declining earnings.
**Example:** A company with steadily increasing EPS is generally more attractive than one whose EPS fluctuates widely from quarter to quarter. For instance, if Company A has an EPS of $2 per share for each of the last five quarters and Company B’s EPS ranges between $1 and $3 over the same period, investors would likely prefer Company A due to its consistent profitability.
ROIC and Capital Efficiency
Return on Invested Capital (ROIC) measures how efficiently a company uses capital to generate profits. Thermo Fisher Scientific Inc has an ROIC of 7.26%, which is below StockValueFinder's preferred range of 10% or higher, indicating that the company may not be using its capital as effectively as competitors.
**Example:** A business with a high ROIC like 15% indicates better use of capital compared to one with an ROIC of only 4%. This means for every dollar invested in Company X versus Company Y, Company X generates significantly more profit per dollar than Company Y.
Interest Coverage and Financial Safety
Interest coverage measures a company’s ability to cover its interest expenses with operating income. Thermo Fisher Scientific Inc did not pass the interest coverage test, meaning it may struggle to meet debt obligations if earnings decline. StockValueFinder prefers companies that have an interest coverage ratio of at least 6.
**Example:** A firm with an interest coverage ratio of 8 can comfortably cover its interest expenses six times over compared to a company with only a 2x ratio, which is barely covering its interest payments and leaves little room for financial flexibility in tough economic conditions.
Debt Payback and Balance Sheet Discipline
Debt payback years indicate how long it would take a company to repay all of its debt using current earnings. Thermo Fisher Scientific Inc has a debt payback period of 5.70 years, which is longer than the preferred threshold of three years or less set by StockValueFinder.
**Example:** A shorter payback period like 1.5 years suggests that a company can repay its debts relatively quickly compared to one with a payback period of seven years, indicating better financial health and lower risk associated with debt obligations.
P/E Ratio and Valuation Discipline
The Price-to-Earnings (P/E) ratio compares the market value of a stock to its earnings per share. Thermo Fisher Scientific Inc has a P/E ratio of 35.54, which is significantly higher than StockValueFinder's preferred range of 15 or lower.
**Example:** A company with a P/E ratio of 8 may be more undervalued compared to one trading at a P/E of 40, assuming the business quality and growth prospects are similar between the two companies. However, a high P/E can also indicate that investors have very optimistic expectations about future earnings.
Moving Average Trend and Entry Timing
The moving average signal for Thermo Fisher Scientific Inc is STRONG BUY TREND, indicating that the stock price has been rising relative to its short-term averages. However, since there are no specific entry signals provided (N/A), this trend does not offer a clear timing opportunity without additional analysis.
**Example:** A strong buy trend suggests that momentum investors might find it attractive to enter positions when prices break above resistance levels or after pullbacks within the overall uptrend pattern.
Overall Financial Strengths and Weaknesses
Thermo Fisher Scientific Inc appears to have significant financial weaknesses according to StockValueFinder's criteria. The company struggles with EPS consistency, capital efficiency (ROIC), interest coverage, debt management, and valuation based on its P/E ratio. These factors contribute to the low overall score of 17% and the AVOID rating.
Risks and Limitations
Investing in Thermo Fisher Scientific Inc involves several risks including high valuation, potential earnings volatility, limited financial flexibility due to higher debt levels, and possibly weaker capital efficiency compared to peers. Investors should consider these factors carefully before making any investment decisions.
Educational Conclusion
This article has provided an educational review of Thermo Fisher Scientific Inc (TMO) using StockValueFinder's metrics. By examining EPS consistency, ROIC, interest coverage, debt payback, P/E ratio, and moving average trends, readers can better understand how to evaluate a company’s financial health and valuation.
Investors should use this information as part of their broader research process rather than relying solely on any single metric or rating system. It is important to conduct thorough due diligence and consider multiple perspectives when making investment decisions.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.